News for Investigators

UCLH has now restarted a high proportion of research studies after having to pause them due to the pandemic.

Researchers can now apply for funding to carry out patient and public involvement (PPI) activities.

The HRA has updated its amendment tool – used by researchers to submit amendments to their research.

The HRA and the devolved administrations have announced new criteria for the approval of standalone student research from 1 September 2021.

A number of BRC-supported researchers have been appointed or re-appointed as National Institute for Health Research (NIHR) Senior Investigators in the NIHR’s 2021 round of awards. New appointments include Professor Robert Heyderman (Infectious Diseases). Re-appointments from UCL include Professor

The NIHR Academy mentoring programme for postdoctoral academy members is now open to all professions and disciplines at post-doctoral level. Feedback from a consultation exercise by the academy in 2020 indicated that it was at this key transition stage where mentorship external to Academy members’

The HRA is updating IRAS and is seeking views on how it should look in the future.

The BRC is looking to develop its support for researchers to encourage better patient and public access to research and trials.

Awards of up to £40,000 are available for researchers in experimental medicine to assemble pilot data.

The Health Research Authority published guidance this week on what sponsors of research studies need to do now that the Transition Period has come to an end.

The HRA has opened a new fast-track research ethics review pilot, which is applicable to UCL sponsored trials.

Funding is available from the Precision AMR (Anti-Microbial Resistance) initiative and Biotechnology company Illumina for one project for the comprehensive and rapid detection of respiratory pathogens and associated resistance genes.

As of 12 November 2020, for commercially sponsored studies the Organisation Information Document (OID) is no longer required as part of the application process through IRAS.

UCLPartners are calling for abstracts with a theme relevant to military clinical practice or research for the ‘Health research and innovation: the Defence Medical Services and the NHS’ online conference on Friday 12 March 2021.

Global life science company Roche has praised UCLH for the speed at which we set up and began an important trial of an immunomodulatory drug in Covid-19.